Chemours outlined full-year 2026 adjusted EBITDA expectations of between $775 million and $825 million while targeting a net leverage ratio of approximately 3.8x by year-end. President and CEO Denise Dignam said second-quarter adjusted EBITDA exceeded expectations, supported by stronger operational performance, an improved product mix in Advanced Performance Materials, lower corporate costs, and pricing strength in Titanium Technologies. Senior Vice President and CFO Shane Hostetter guided third-quarter consolidated adjusted EBITDA to a range of $175 million to $205 million, with a sharp sequential decline in Thermal and Specialized Solutions due to aftermarket destocking, and set full-year net sales growth of 1% to 5% over 2025 alongside free cash flow conversion above 25%. Management also signaled openness to portfolio actions, with Dignam stating that no portfolio action is off the table where it can unlock a step change in shareholder value.
Chemours CoCompany provides 2026 EBITDA guidance and leverage target, with Q2 beat and pricing strength.
